Comment on ‘A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens’

von Normanno, N, Rachiglio, A, Roma, C, Ciardiello, F, Pinto, C
Veröffentlicht 2012

Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy

von Martinelli, E, De Palma, R, Orditura, M, De Vita, F, Ciardiello, F
Veröffentlicht 2009

Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management

von McLellan, B., Ciardiello, F., Lacouture, M. E., Segaert, S., Van Cutsem, E.
Veröffentlicht in Ann Oncol (2015)

Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.

von Hynes, N E, Taverna, D, Harwerth, I M, Ciardiello, F, Salomon, D S, Yamamoto, T, Groner, B
Veröffentlicht 1990

Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs

von Bianco, R, Garofalo, S, Rosa, R, Damiano, V, Gelardi, T, Daniele, G, Marciano, R, Ciardiello, F, Tortora, G
Veröffentlicht 2008

Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs

von Gelardi, T, Caputo, R, Damiano, V, Daniele, G, Pepe, S, Ciardiello, F, Lahn, M, Bianco, R, Tortora, G
Veröffentlicht 2008

Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.

von Normanno, N, Selvam, M P, Qi, C F, Saeki, T, Johnson, G, Kim, N, Ciardiello, F, Shoyab, M, Plowman, G, Brandt, R
Veröffentlicht 1994

Differential expression of epidermal growth factor-related proteins in human colorectal tumors.

von Ciardiello, F, Kim, N, Saeki, T, Dono, R, Persico, M G, Plowman, G D, Garrigues, J, Radke, S, Todaro, G J, Salomon, D S
Veröffentlicht 1991

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.

von Qi, C. F., Liscia, D. S., Normanno, N., Merlo, G., Johnson, G. R., Gullick, W. J., Ciardiello, F., Saeki, T., Brandt, R., Kim, N.
Veröffentlicht 1994

Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors

von Morgillo, F, Cascone, T, D'Aiuto, E, Martinelli, E, Troiani, T, Saintigny, P, De Palma, R, Heymach, J V, Berrino, L, Tuccillo, C, Ciardiello, F
Veröffentlicht 2011

FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer

von Bokemeyer, C., Köhne, C.-H., Ciardiello, F., Lenz, H.-J., Heinemann, V., Klinkhardt, U., Beier, F., Duecker, K., van Krieken, J.H., Tejpar, S.
Veröffentlicht in Eur J Cancer (2015)

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

von Macarulla, T, Cervantes, A, Tabernero, J, Roselló, S, Van Cutsem, E, Tejpar, S, Prenen, H, Martinelli, E, Troiani, T, Laffranchi, B, Jego, V, von Richter, O, Ciardiello, F
Veröffentlicht in Br J Cancer (2015)

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six ran...

von Arnold, D., Lueza, B., Douillard, J.-Y., Peeters, M., Lenz, H.-J., Venook, A., Heinemann, V., Van Cutsem, E., Pignon, J.-P., Tabernero, J., Cervantes, A., Ciardiello, F.
Veröffentlicht in Ann Oncol (2017)

PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

von Van Cutsem, E., Ciardiello, F., Ychou, M., Seitz, J.-F., Hofheinz, R., Arriaga, Y., Garcia-Carbonero, R., Grothey, A., Miriyala, A., Kalmus, J., Kappeler, C., Falcone, A., Zaniboni, A.
Veröffentlicht in Ann Oncol (2016)

A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC)

von Aurilio, G, Ricci, V, De Vita, F, Fasano, M, Fazio, N, Orditura, M, Funicelli, L, De Luca, G, Iasevoli, D, Iovino, F, Ciardiello, F, Conzo, G, Nolè, F, Lamendola, MG
Veröffentlicht 2010

Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression

von Napolitano, S., Matrone, N., Muddassir, A. L., Martini, G., Sorokin, A., De Falco, V., Giunta, E. F., Ciardiello, D., Martinelli, E., Belli, V., Furia, M., Kopetz, S., Morgillo, F., Ciardiello, F., Troiani, T.
Veröffentlicht in J Exp Clin Cancer Res (2019)

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

von Ciardiello, F, Troiani, T, Caputo, F, De Laurentiis, M, Tortora, G, Palmieri, G, De Vita, F, Diadema, M R, Orditura, M, Colantuoni, G, Gridelli, C, Catalano, G, De Placido, S, Bianco, A R
Veröffentlicht 2006

Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells

von Troiani, T, Vecchione, L, Martinelli, E, Capasso, A, Costantino, S, Ciuffreda, L P, Morgillo, F, Vitagliano, D, D'Aiuto, E, De Palma, R, Tejpar, S, Van Cutsem, E, De Lorenzi, M, Caraglia, M, Berrino, L, Ciardiello, F
Veröffentlicht 2012

Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer

von Morgillo, F., De Vita, F., Antoniol, G., Orditura, M., Auriemma, P.P., Diadema, M.R., Lieto, E., Savastano, B., Festino, L., Laterza, M.M., Fabozzi, A., Ventriglia, J., Petrillo, A., Ciardiello, F., Barbarisi, A., Iovino, F.
Veröffentlicht 2013

Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells

von D'Amato, C, Rosa, R, Marciano, R, D'Amato, V, Formisano, L, Nappi, L, Raimondo, L, Di Mauro, C, Servetto, A, Fulciniti, F, Cipolletta, A, Bianco, C, Ciardiello, F, Veneziani, B M, De Placido, S, Bianco, R
Veröffentlicht in Br J Cancer (2014)